ArticleNeuro-oncology2020

Actinomycin D downregulates Sox2 and improves survival in preclinical models of recurrent glioblastoma.

Jessica T Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.